TriWise
TriWise Capital is an investment firm that focuses on venture capital and M&a;A business.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed TriWise Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
TriWise Capital is an investment firm that focuses on venture capital and M&a;A business.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2019 | Akeso Biopharma | Series D | 150M |
| 11/2021 | Triastek | Series B | - |
| 12/2021 | Innoforce Pharmaceuticals | Series A | 0 |
| 6/2021 | Inmagene Biopharmaceuticals | Series C | 0 |
| 1/2019 | Immvira | Series A | 15M |
| 7/2021 | Adlai Nortye | Series D | 0 |
| 10/2018 | Akeso Biopharma | Series C | 4.1M |
| 11/2020 | Asieris Pharmaceuticals | Series D | 0 |
| 1/2023 | Immune-Onc Therapeutics | Series B | 25M |
| 8/2017 | Akeso Biopharma | Series B | 45.5M |
| 6/2021 | Triastek | Series B | 0 |
| 3/2022 | Qyuns Therapeutics | Series C | 15.8M |
| 7/2019 | Qyuns Therapeutics | Series B | 20M |
| 3/2022 | Qyuns Therapeutics | Series C | 0 |
| 12/2021 | Innoforce Pharmaceuticals | Series A | 0 |
| 11/2021 | Triastek | Series B | - |
| 7/2021 | Adlai Nortye | Series D | 0 |
| 6/2021 | Triastek | Series B | 0 |
| 6/2021 | Inmagene Biopharmaceuticals | Series C | 0 |
| 11/2020 | Asieris Pharmaceuticals | Series D | 0 |
| 11/2019 | Akeso Biopharma | Series D | 0 |
| 7/2019 | Qyuns Therapeutics | Series B | 0 |
| 1/2019 | Immvira | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
